Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CCME GlobalBOM:514336 -0.42%26 PB Ratio is 13.26 as of Jul. 27, 2026, which is 1479% above its 10-year median of 0.84. GuruFocus rates BOM:514336 with a GF Score™ of 26/100. The stock has 2 warning signs investors should review. Among 1,230 Biotechnology companies, CCME Global ranks worse than 89.84% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-27), CCME Global's share price is ₹117.40. CCME Global's Book Value per Share for the quarter that ended in Mar. 2026 was ₹8.86. Hence, CCME Global's PB Ratio of today is 13.26.
Warning Sign:
CCME Global Ltd stock PB Ratio (=13.31) is close to 10-year high of 13.31.
The historical rank and industry rank for CCME Global's PB Ratio or its related term are showing as below:
BOM:514336'
s PB Ratio Range Over the Past 10 Years
Min: 0.59 Med: 0.84 Max: 13.31
Current: 13.25
During the past 13 years, CCME Global's highest PB Ratio was 13.31. The lowest was 0.59. And the median was 0.84.
BOM:514336's PB Ratio is ranked worse than 89.84% of 1230
companies
in the Biotechnology industry
Industry Median: 2.785
vs BOM:514336: 13.25
During the past 12 months, CCME Global's average Book Value Per Share Growth Rate was 34.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 9.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 1.40% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -0.50% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of CCME Global was 171.40% per year. The lowest was -75.00% per year. And the median was 0.45% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
CCME Global PB Ratio Related Terms
CCME Global PB Ratio Historical Data
* Premium members only.
The historical data trend for CCME Global's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:514336 vs VRTX, REGN, RVMD: PB Ratio Comparison
For the Biotechnology subindustry, CCME Global's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CCME Global PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, CCME Global's PB Ratio distribution charts can be found below:
* The bar in red indicates where CCME Global's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
CCME Global's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
CCME Global (BOM:514336) has a PB Ratio of 13.26 as of Jul. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on CCME Global and its competitors. This is 1479% above median its historical median of 0.84. Over the past decade, CCME Global's PB Ratio has ranged from 0.59 to 13.31. According to the industry distribution chart, CCME Global ranks #1105 out of 1230 companies in the Biotechnology industry, placing it in the top 89.8%.
Is CCME Global's PB Ratio too high?
CCME Global's current PB Ratio of 13.26 is 1479% above median its 10-year median of 0.84. Over the past 10 years, this metric has ranged from a low of 0.59 to a high of 13.31. The Biotechnology industry median PB Ratio is 2.79. CCME Global's value of 13.26 is 376.1% above this industry median. Based on the distribution chart, CCME Global ranks #1105 out of 1230 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, CCME Global has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does CCME Global's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CCME Global ranks #1105 out of 1230 companies for PB Ratio. This places CCME Global in the lower half of its industry. The industry median PB Ratio is 2.79. CCME Global's value of 13.26 is 376.1% above this benchmark. Historically, CCME Global's own PB Ratio has ranged from 0.59 to 13.31 over the past decade. While the company's 10-year median is 0.84 vs. the industry median of 2.79, CCME Global has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.79, based on 1,230 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CCME Global's current PB Ratio of 13.26 is 376.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on CCME Global and its competitors. For the Biotechnology industry, the median PB Ratio is 2.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CCME Global's current PB Ratio is 13.26, which is 1479% above median its own 10-year median of 0.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CCME Global stock overvalued right now?
CCME Global (BOM:514336) has a current PB Ratio of 13.26. The current PB Ratio is 13.26, which is 1479% above median its 10-year median of 0.84 and 376.1% above the Biotechnology industry median of 2.79. CCME Global's overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For CCME Global (BOM:514336), the current PB Ratio is 13.26 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CCME Global Ltd, formerly known as Genesis IBRC India Ltd, is a manufacturer and supplier of Aqua, poultry, veterinary and agriculture products. The product profile promotes health and illness prevention in Aquaculture, poultry and veterinary.
26GF Score
Get the complete analysis for BOM:514336
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:514336 has been successfully added to your 
